Changes in Transmucosal Buprenorphine Utilization for Opioid Use Disorder Treatment During the COVID-19 Pandemic in Kentucky
Explores changes in prescription rates of transmuscosal buprenorphine for the treatment of opioid use disorder during the COVID-19 pandemic in Kentucky. Compares prescribing rates in rural versus urban areas and examines rates on a week by week basis.
Feitong Lei, Michelle R. Lofwall, Patricia R. Freeman, et al.
Journal of Rural Health, 39(1), 186-196
Access · COVID-19 · Illicit drug use · Pharmacy and prescription drugs · Prescription drug misuse · Rural-urban differences · Statistics and data · Wellness, health promotion, and disease prevention · Kentucky